@article{cc86d1ce36204564ada85f0380e829be,
title = "[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice",
abstract = "Belinostat is a histone deacetylase inhibitor with anti-tumor effect in several pre-clinical tumor models and clinical trials. The aim of the study was to evaluate changes in cell proliferation and glucose uptake by use of 3'-deoxy-3'-[(18)F]fluorothymidine ([18F]FLT) and 2-deoxy-2-[(18)F]fluoro-D-glucose ([18F]FDG) positron emission tomography (PET) following treatment with belinostat in ovarian cancer in vivo models.",
keywords = "Animals, Antineoplastic Agents, Dideoxynucleosides, Disease Models, Animal, Female, Fluorodeoxyglucose F18, Glucose Transporter Type 1, Humans, Hydroxamic Acids, Ki-67 Antigen, Mice, Ovarian Neoplasms, Positron-Emission Tomography, Radiopharmaceuticals, Sulfonamides, Thymidine Kinase, Tumor Burden",
author = "Jensen, {Mette Munk} and Erichsen, {Kamille Dumong} and Johnbeck, {Camilla Bardram} and Fredrik Bj{\"o}rkling and Jacob Madsen and Jensen, {Peter Buhl} and Maxwell Sehested and Liselotte H{\o}jgaard and Andreas Kj{\ae}r",
year = "2013",
doi = "10.1186/1471-2407-13-168",
language = "English",
volume = "13",
pages = "168",
journal = "B M C Cancer",
issn = "1471-2407",
publisher = "BioMed Central Ltd",
}